Pd0-mediated rapid C-[11C]methylations and C-[ 18F]fluoromethylations: Revolutionary new methodologies for the synthesis of short-lived PET molecular probes

Yuki Gosei Kagaku Kyokaishi/Journal of Synthetic Organic Chemistry

Volumn 68, Issue 11, 2010, Pages 1195-1206

  Suzuki, Masaaki ^a   Doi, Hisashi ^a  

^a RIKEN   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON FRAMEWORK; CROSS COUPLING REACTIONS; IN-VIVO; MOLECULAR PROBES; MOLECULAR SCIENCE; ORGANOBORON COMPOUND; RAPID REACTIONS;

ALKYLATION; BORON COMPOUNDS; BROMINE COMPOUNDS; CHEMICAL BONDS; METHYLATION; PROBES; SYNTHESIS (CHEMICAL);

PALLADIUM;

EID: 79551513244     PISSN: 00379980     EISSN: None     Source Type: Journal    
DOI: 10.5059/yukigoseikyokaishi.68.1195     Document Type: Article

References (81)

1. (a) Phelps, M. E. In PET: Molecular Imaging and Its Biological Applications; Springer, New York, Berlin, Heidelberg, 2004.
2. (b) In Positron Emission Tomography; Bailey, D. L.; Townsend, D. W.; Valk, P. E.; Maisey, M. N., Eds.; Basic Science, Springer, New York, Berlin, Heidelberg, 2005.
3. (a) Lappin, G.; Garner, R. C., Nat. Rev. Drug Discov. 2003, 2 (3), 233.
4. (b) Bergström, M.; Grahnén, A.; Långström, B., Eur. J. Clin. Pharmacol. 2003, 59 (5-6), 35.
5. The European Medicines Agency, Evaluation of Medicines for Human Use, Position paper on non-clinical safety studies to support clinical trials with a single microdose, CPMP/SWP/2599/02/Rev1, June 23, 2004;
6. U. S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research, Guidance for Industry, Investigators, and Reviewers, Exploratory IND Studies, January 2006;
7. e) Japan's response to microdosing study, Notification No. 0603001, June 3,2008, Guidance for the Conduct of Microdosing Clinical Trials, Evaluation and Licensing Division, Pharmaceutical and Food Safety Bureau, Ministry of Health, Labour and Welfare, Japan.
8. (a) In PET Chemistry. The Driving Force in Molecular Imaging; Schubiger, P. A.; Lehmann, L.; Friebe, M., Eds.; Springer, New York, Berlin, Heidelberg, 2007.
9. (b) Fowler, J. S.; Wolf, A. P., Accounts Chem. Res. 1997, 30 (4), 181.
10. (a) Suzuki, M.; Doi, H.; Björkman, M.; Andersson, Y; Långström, B.; Watanabe, Y.; Noyori, R., Chem. Eur. J. 1997, 3, 2039.
11. (b) Hosoya, T.; Wakao, M.; Kondo, Y.; Doi, H.; Suzuki, M., Org Biomol. Chem. 2004, 2, 24.
12. Hosoya, T.; Sumi, K.; Doi, H.; Wakao, M.; Suzuki, M., Org Biomol. Chem. 2006, 4, 410.
13. Doi, H.; Ban, I.; Nonoyama, A.; Sumi, K.; Kuang, C. X.; Hosoya, T.; Tsukada, H.; Suzuki, M., Chem. Eur. J. 2009, 15, 4165.
14. (e) Suzuki, M.; Sumi, K.; Koyama, H.; Siqin; Hosoya, T; Takashima-Hirano, M.; Doi, H., Chem. Eur. J. 2009, 15, 12489.
15. (a) Bjòrkman, M.; Doi, H.; Resul, B.; Suzuki, M.; Noyori, R.; Watanabe, Y.; Långström, B., J Labelled Compd Radiopharm. 2000, 43, 1327.
16. (b) Tarkiainen, J.; Vercouille, J.; Emond, P.; Sandell, J.; Hiltunen, J.; Frangin, Y; Guilloteau, D.; Halldin, C., J. Labelled Compd. Radiopharm. 2001, 44, 1013.
17. Sandell, J.; Yu, M.; Emond, P.; Garreau, L.; Chalon, S.; Någren, K.; Guilloteau, D.; Halldin, C., Bioorg Med Chem. Lett. 2002, 12, 3611.
18. Sandell, J.; Halldin, C.; Sovago, J.; Chou, Y-H.; Gulyás, B.; Yu, M.; Emond, P.; Någren, K.; Guilloteau, D.; Farde, L., Nucl. Med Biol. 2002, 29, 651.
19. (e) Gerasimov, M. R.; Ferrieri, R. A.; Schiffer, W. K.; Logan, J.; Gatley, S. J.; Gifford, A. N.; Alexoff, D. A.; Marstellar, D. A.; Shea, C.; Garza, V; Carter, P.; King, P.; Ashby, C. R.; Vitkun, S.; Dewey, S. L., Life Sci. 2002, 70, 2811.
20. (f) Gerasimov, M. R.; Logan, J.; Ferrieri, R. A.; Muller, R. D.; Alexoff, D.; Dewey, S. L., Nucl. Med Biol. 2002, 29, 607.
21. (g) Karimi, E; Långström, B., J. Labelled Compd Radiopharm. 2002, 45, 423.
22. (h) Samuelsson, L.; Långström, B., J. Labelled Compd Radiopharm. 2003, 46, 263.
23. Kim, H. S.; Ohno, M.; Xu, B.; Kim, H. O.; Choi, Y. S.; Ji, X. D.; Maddileti, S.; Marquez, V. E.; Harden, T. K.; Jacobson, K. A., J. Med Chem. 2003, 46, 4974.
24. (j) Madsen, J.; Merachtsaki, P.; Davoodpour, P.; Bergström, M.; Långström, B.; Andersen, K.; Thomsen, C.; Martiny, L.; Knudsen, G. M., Bioorg. Med Chem. 2003, 11, 3447.
25. (k) Langer, O.; Forngren, T.; Sandell, J.; Dollé, E; Långström, B.; Någren, K.; Halldin, C., J. Labelled Compd. Radiopharm. 2003, 46, 55.
26. lida, Y; Ogawa, M.; Ueda, M.; Tominaga, A.; Kawashima, H.; Magata, Y.; Nishiyama, S.; Tsukada, H.; Mukai, T.; Saji, H., J. Nucl. Med. 2004, 45, 878.
27. Huang, Y. Y.; Narendran, R.; Bischoff, F.; Guo, N.; Zhu, Z.; Bae, S.-A.; Lesage, A. S.; Laruelle, M., J. Med Chem. 2005, 48, 5096.
28. (n) Prabhakaran, J.; Majo, V. J.; Simpson, N. R.; Van Heertum, R. L.; Mann, J. J.; Kumar, J. S. D., J. Labelled Compd Radiopharm. 2005, 48, 887.
29. (o) Bennacef, I.; Perrio, C.; Lasne, M. C.; Barré, L., J. Org Chem. 2007, 72, 2161.
30. (p) Zeng, E; Mun, J.; Jarkas, N.; Stehouwer, J. S.; Voll, R. J.; Tamagnan, G. D.; Howell, L.; Votaw, J. R.; Kilts, C. D.; Nemeroff, C. B.; Goodman, M. M., J. Med Chem. 2009, 52, 62.
31. (a) Stille, J. K., Angew. Chem., Int. Ed Engl. 1986, 25, 508. For reviews of the Stille reaction, see:
32. (b) Farina, V; Krishnamurthy, V; Scott, W. J. Org React. 1997, 50, 1-652.
33. nd edn; Diederich, F., Stang, P. J., Eds.; Wiley-VCH: New York, 1998; pp 125-162.
34. Fugami, K.; Kosugi, M. Top. Curr. Chem. 2002, 219, 87-130.
35. (a) Morita, D. K.; Stille, J. K.; Norton, J. R., J. Am. Chem. Soc. 1995, 117, 8576.
36. (b) Andersson, Y.; Cheng, A. P.; Långström, B., Acta Chem. Scand. 1995, 49, 683.
37. Paul, F.; Patt, J.; Hartwig, J. F., Organometallics 1995, 14, 3030.
38. Tolman, C. A. Chem. Rev. 1997, 77, 313.
39. SaáJ. M.; Martorell, G., J. Org Chem. 1993, 58, 1963.
40. (a) Liebeskind, L. S.; Fengl, R. W., J. Org Chem. 1990, 55, 5359.
41. (b) Falck, J. R.; Bhatt, R. K.; Ye, J., J. Am. Chem. Soc. 1995, 117, 5973, also see references cited therein.
42. Louie, J.; Hartwig, J. F., J. Am. Chem. Soc. 1995, 117, 11598.
43. (a) Suzuki, M.; Kato, K.; Noyori, R.'; Watanabe, Yu.; Takechi, H.; Matsumura, K.; Långström, B.; Watanabe, Y., Angew. Chem., Int. Ed Engl. 1996, 35, 334.
44. (b) Takechi, H.; Matsumura, K.; Watanabe, Yu.; Kato, K.; Noyori, R.; Suzuki, M.; Watanabe, Y., J. Biol. Chem. 1996, 271, 5901.
45. 2 in a cyclotron.
46. (a) Björkman, M.; Andersson, Y.; Doi, H.; Kato, K.; Suzuki, M.; Noyori, R.; Watanabe, Y.; Långström, B., Acta Chem. Scand. 1998, 52, 635.
47. (b) Suzuki, M.; Noyori, R.; Långström, B.; Watanabe, Y, Bull. Chem. Soc. Jpn. 2000, 73, 1053.
48. Suzuki, M.; Doi, H.; Hosoya, T.; Långström, B.; Watanabe, Y., TrAC, Trends Anal. Chem. 2004, 23, 595.
49. Suzuki, M.; Doi, H.; Kato, K.; Björkman, M.; Långström, B.; Watanabe, Y.; Noyori, R., Tetrahedron 2000, 56, 8263.
50. 11C]-8 was 37-100 GBq/|μmol. The total synthesis time was 35-40 min.
51. 11C-labeled compound by mechanical synthesis under PET radiolabeling conditions.
52. Noyori, R., Angew. Chem., Int. Ed. Engl. 2002, 41, 2008.
53. Cui, Y.; Takamatsu, H.; Kakiuchi, T.; Ohba, H.; Kataoka, Y.; Yokoyama, C.; Onoe, H.; Watanabe, Yu.; Hosoya, T.; Suzuki, M.; Noyori, R.; Tsukada, H.; Watanabe, Y., Stroke 2006, 37, 2830.
54. (a) Menzel, K.; Fu, G. C., J. Am. Chem. Soc. 2003, 125, 3718.
55. (b) Tang, H.; Menzel, K.; Fu, G. C., Angew. Chem., Int. Ed Engl. 2003, 42, 5079.
56. Mee, S. P. H.; Lee, V.; Baldwin, J. E., Angew. Chem., Int. Ed Engl. 2004, 45, 1132.
57. (a) Skuballa, W.; Vorbrüggen, H., Angew. Chem., Int. Ed Engl. 1981, 20, 1046.
58. (b) Skuballa, W; Vorbrüggen, H., Adv. Prostaglandin Thromboxane Leukot. Res. 1983, 11, 299;
59. Collins, P. W; Djuric, S. W., Chem. Rev. 1993, 93, 1533.
60. (b) Buchman, B., In Prostaglandins, Leukotriens and Other Eicosanoids, Marks, F., Fürstenberger, Eds.; Wiley-VCH, Weinheim, 1999, 331-374.
61. Wise, H.; Jones, R. L., In Prostacyclin and Its Receptors, Kluwer Academic/Plenum Publishers, New York, 2000.
62. Wakita, H.; Yoshiwara, H.; Nishiyama, H.; Nagase, H., Heterocycles 2000, 53, 1085, and see references cited therein.
63. Cushman, M.; Mohanakrishnan, A. K.; Hollingshead, M.; Hamel, E., J. Med Chem. 2002, 45, 4748.
64. Teutsch, G.; Gaillard-Moguilewsky, M.; Lemoine, G.; Nique, E; Philibert, D., Biochem. Soc. Trans. 1991, 19, 901.
65. Hoshino, Y; Miyazawa, S.; Nakata, H.; Etoh, H.; Furitsu, M.; Abe, S., J. Labelled Compd Radiopharm. 1997, 39, 109.
66. De Clercq, E.; Descamps, J.; Balzarini, J.; Giziewicz, J.; Barr, P. J.; Robins, M. J., J. Med Chem. 1983, 26, 661.
67. 11C]-14 will be reported in due course.
68. Littke, A. F.; Schwarz, L.; Fu, G. C., J. Am. Chem. Soc. 2002, 124, 6343.
69. Hostetler, E. D.; Terry, G. E.; Burns, H. D., J. Labelled Compd Radiopharm. 2005, 48, 629.
70. For reviews of the Suzuki-Miyaura reaction, see: a) Miyaura, N.; Suzuki, A., Chem. Rev. 1995, 95, 2457.
71. b) Suzuki, A., J. Organomet. Chem. 1999, 576, 147.
72. Suzuki, A. In Modern Arene Chemistry, Astruc, D., Ed.; Wiley-VCH, 2002, 53-106.
73. Suzuki, A. Brown, H. C. In Suzuki Coupling, Organic Syntheses via Boranes, Vol. 3., Aldrich Chemical, 2003.
74. e) Suzuki, A., Proc. Jpn. Acad. 2004, Ser. B 80, 359. For the cross-coupling reactions between alkyl iodide and boron compounds by the Suzuki-Miyaura reaction,
75. i) Ishiyama, T.; Abe, S.; Miyaura, N.; Suzuki, A., Chem. Lett. 1992, 691.
76. j) Gooßen, L. J., Applied Organomet. Chem. 2004, 18, 602.
77. th European Symposium on Radiopharmacy and Radiopharmaceuticals, Edinburgh, Scotland, April 8-11, 2010,
78. see abstract, Q. J. Nucl. Med. Mol. Imaging 2010 Apr., 54, 18.
79. Personal communication: Suzuki, M.; Koyama, H.; Ijuin, R.; Doi, H., et al.
80. Takashima-Hirano, M.; Shukuri, M.; Takashima, T.; Goto, M.; Wada, Y.; Watanabe, Y; Onoe, H.; Doi, H.; Suzuki, M., Chem. Eur. J. 2010, 16, 4250.
81. 11C] methylation of Flurbiprofen methyl ester.